Chronic Granulomatous Disease (CGD)
Clinical Features and Laboratory Testing
Relative Distribution of the PIDs

January 2010
The PIDs can be classified based on the component of the immune system that are affected - these include humoral or B cell defects, T cell or cellular defects, phagocytic defects and complement defects. The humoral or antibody deficiencies account for the majority of the PIDs, ~65%, while "pure" cellular deficiencies account for only 5% of the total cases of PIDs. The combined cellular and humoral immune deficiencies account for another 15%, while the phagocytic and complement deficiencies account for the remaining 10% and 5% respectively.
Relative Distribution |
Jump to section:
- Introduction
- Primary Immunodeficiencies (PIDs): What Are They?
- Primary Immunodeficiencies (PIDs): What Are They?
- Relative Distribution of the PIDs
- Components and Kinetics of the Immune Response
- Mechanisms of Innate Immunity
- Defect in the Innate Immune System: Chronic Granulomatous Disease
- Molecular Pathogenesis
- Clinical Features
- Laboratory Diagnosis of Neutrophil Oxidative Burst
- Nitro Blue-Tetrazolium Test (NBT)
- Dihydrorhodamine (DHR) Flow Cytometric Assay for Diagnosis of CGD
- Neutrophil Oxidative Burst: Normal Individual
- X-linked CGD
- Symptomatic Female Carrier with CGD
- Autosomal Recessive CGD
- Autosomal Recessive CGD
- Laboratory Test Ordering Information
- Questions?


